Starting a drug manufacturing business in India in 2026 offers strong potential. Rising domestic demand, global export opportunities, and supportive government policies are the driving factors for this booming industry. However, success requires strict compliance with...
Mandatory Schedule M compliance is being enforced to establish India as a global pharmaceutical manufacturing hub. The Schedule M is aimed increasing the accountability of pharmaceutical manufacturers for the quality and efficacy of the pharmaceutical products. The...
You cannot copy content of this page
Contact Us!
Chat with Us on WhatsApp! We reply within 5 minutes!
